Total submissions: 11
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Clin |
RCV002281058 | SCV002569934 | benign | FOXG1 disorder | 2022-08-25 | reviewed by expert panel | curation | The allele frequency of the p.Ala149= variant in FOXG1 is 0.227% in European (Non-Finnish) sub population in gnomAD, which is high enough to be classified as benign based on thresholds defined by the ClinGen Rett/Angelman-like Expert Panel for Rett/AS-like conditions (BA1). The silent p.Ala149= variant is not predicted to affect splicing using multiple computational tools and does not affect a highly conserved nucleotide (BP7). In summary, the p.Ala149= variant in FOXG1 is classified as benign based on the ACMG/AMP criteria (BA1, BP7). |
Gene |
RCV000415955 | SCV000168582 | benign | not provided | 2019-09-11 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV000145989 | SCV000193138 | benign | not specified | 2017-06-22 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000145989 | SCV000224472 | likely benign | not specified | 2016-04-28 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000415955 | SCV000493531 | likely benign | not provided | 2024-02-01 | criteria provided, single submitter | clinical testing | FOXG1: BP4, BP7, BS1 |
Invitae | RCV000545830 | SCV000650049 | benign | Rett syndrome, congenital variant | 2024-01-22 | criteria provided, single submitter | clinical testing | |
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000545830 | SCV000745497 | likely benign | Rett syndrome, congenital variant | 2017-08-02 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002316366 | SCV000851227 | likely benign | Inborn genetic diseases | 2016-09-07 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Prevention |
RCV003905199 | SCV004725394 | likely benign | FOXG1-related condition | 2019-08-27 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Diagnostic Laboratory, |
RCV000545830 | SCV000733375 | likely benign | Rett syndrome, congenital variant | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000415955 | SCV001957892 | likely benign | not provided | no assertion criteria provided | clinical testing |